Antibiotic prevention for certain liver disease patients
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests whether taking preventive antibiotics can help people with certain liver conditions avoid infections after an endoscopy-related procedure. It may reduce infection risk, but it also requires that you have no signs of infection and haven’t recently taken antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have live cirrhosis and/or a liver tumor (hepatoma)
- You are between 20 and 85 years old
- You recently had an endoscopy-related treatment and were found to have EV(-)GV(+) or EV less than GV
- You do not have a terminal illness affecting major organs (for example severe heart, kidney, or lung disease)
- You have not taken antibiotics recently
- You do not currently seem to have an infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving antibiotics before liver or bile duct surgery can prevent wound infections in areas where bacteria are resistant to many antibiotics. You would receive antibiotics as a preventive measure and be monitored for any surgical site infections.
This study compares two ways of giving preventive antibiotics to liver transplant patients who carry resistant bacteria. The goal is to see if targeted antibiotics work better than standard ones at preventing infections without causing more side effects.
This study compares two strong antibiotics—ceftazidime-avibactam and a high dose of meropenem given over a longer infusion—in patients with advanced liver disease who develop a hospital-acquired infection. The goal is to see which works better and is safer.
This early-stage study tests whether giving preventive (prophylactic) antibiotics helps prevent infections when an external brain fluid drain (EVD) is placed and used. It may help lower the chance of serious infections around the drain.
This trial tests whether adding a probiotic (Bifidobacterium) to standard antibiotic treatment works better for treating spontaneous bacterial peritonitis (an infection in the belly fluid caused by liver cirrhosis) and preventing it from coming back.
This trial tests whether giving a mixture of helpful bacteria can improve gut health in people hospitalized with serious liver problems. It aims to see if restoring these bacteria can help with recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.